More Articles


Communicate Your Way to a Better Patient Experience

Deirdre Coleman, (Mar 31, 2017)

Making patients feel part of the team during a clinical trial can transform the trial experience for the better

Active Partners in Research

Deirdre Coleman, (Mar 29, 2017)

GSK are tapping into their consumer division's skill of capturing consumer insights - could FMCI (Fast-Moving Consumer Insights) be the way forward?

The Missing Link to Real-World Innovation

Jack Fitzgerald, (Mar 28, 2017)

The pharma industry loves digital pilots but struggles to translate them into live services

Tackling a Decade of Change

Hugh Gosling, (Mar 23, 2017)

Pharma must offer genuine solutions if it is to survive the challenges ahead, says Alistair Grenfell from QuintilesIMS

Shire: Standing Up For Patients

Hugh Gosling, (Mar 20, 2017)

Pharma companies must champion their patients to ensure their voices are heard, says Shire’s Perry Sternberg
Market Access

Arbiter of Value

Deirdre Coleman, (Mar 17, 2017)

ICER has the laudable mission of being an independent, trusted source of value assessment for medicines. We spoke to Chief Scientific Officer, Dan Ollendorf, about controversy, criticism and the power of collaboration.

Medical Affairs Disrupted

Deirdre Coleman, (Mar 16, 2017)

How do we optimize medical affairs to engage patients, understand their needs and create patient-centric medical information exchange

Patient Engagement: Great Expectations

Danielle Barron, (Mar 15, 2017)

Pharma needs to be nimble if it is to meet patients’ high expectations
Market Access

Oncology: Solving the Value Conundrum

Danielle Barron, (Mar 14, 2017)

Value-based contracts represent a genuine opportunity to build resilient relationships with payers - if pharma can overcome the practical issues

Otsuka: Keeping an Open Mind

Hugh Gosling, (Mar 13, 2017)

Embrace technology and collaborate with reputable partners to deliver truly patient-centric solutions, says Otsuka USA President, Kabir Nath